Multidrug-resistant Acinetobacter extremity infections in soldiers

Emerging Infectious Diseases

Volumn 11, Issue 8, 2005, Pages 1218-1224

  Davis, Kepler A ^a   Moran, Kimberly A ^b   McAllister, C Kenneth ^a   Gray, Paula J ^a  

^a BROOKE ARMY MEDICAL CENTER   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; CEFEPIME; CEFOTETAN; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; SULTAMICILLIN; TOBRAMYCIN;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ADULT; AFGHANISTAN; ARTICLE; BACTERIUM CULTURE; BATTLE INJURY; BURN INFECTION; CONTROLLED STUDY; DEBRIDEMENT; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IRAQ; LIMB DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; OSTEOMYELITIS; RECURRENT INFECTION; SOLDIER; TREATMENT OUTCOME; UNITED STATES; WOUND INFECTION;

EID: 22944472985     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/1108.050103     Document Type: Article

References (25)

1. Data from Department of Defense, Directorate for Information Operations and Reports. [accessed 18 Apr 2005]. Available from www.dior.whs.mil/mmid/ casualty/castop.htm
2. Centers for Disease Control and Prevention. Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004. MMWR Morb Mortal Wkly Rep. 2004;53:1063-6.
3. Tong, MJ. Septic complications of war wounds. JAMA. 1972;219:1044-7.
4. Berezin EB, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev. 1996;9:148-65.
5. Lew DP, Waldvogel FA. Osteomyelitis. Lancet. 2004;364:369-79.
6. Waldvogel FA, Vasey H. Osteomyelitis: the past decade. N Engl J Med. 1980;303:360-70.
7. Lazzarini L, Mader JT, Calhoun JH. Osteomyelitis in long bones. J Bone Joint Surg Am. 2004;86:2305-18.
8. Urban C, Segal-Maurer S, Rahal JJ. Considerations in control and treatment of nosocomial infections due to multi-drug resistant Acinetobacter baumannii. Clin Infect Dis. 2003;36:1268-74.
9. NCCLS. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A8. Wayne (PA): The Committee; 2003.
10. Gales AC, Reis AO, Jones RN. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin b and colistin: review of available interpretative criteria and quality control guidelines. J Clin Microbiol. 2001;39:183-90.
11. Glew RH, Moellering RC, Kunz LJ. Infections with Acinetobacter calcoaceticus (Herellea vaginicola): clinical and laboratory studies. Medicine (Baltimore). 1977;56:79-97.
12. Wisplinghoff H, Edmond MB, Pfaller MA, Jones RN, Wenzel RP, Seifert H. Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility. Clin Infect Dis. 2000;31:690-7.
13. Valles J, Leon C, Alvarez-Lerma F. Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis. Clin Infect Dis. 1997;24:387-95.
14. Wisplinghoff H, Perbix W, Seifert H. Risk factors for nosocomial bloodstream infections due to Acinetobacter baumannii: a case-control study of adult burn patients. Clin Infect Dis. 1999;28:59-66.
15. Poutanen SM, Louie M, Simor AE. Risk factors, clinical features, and outcome of Acinetobacter bacteremia in adults. Eur J Clin Microbiol Infect Dis. 1997;16:737-40.
16. Martin RW, Martin DL, Levy CS. Acinetobacter osteomyelitis from a hamster bite. Pediatr Infect Dis J. 1988;7:364-5.
17. Volpin G, Krivoy N, Stein H. Acinetobacter sp. osteomyelitis of the femur: a late sequela of unrecognized foreign body implantation. Injury. 1993;24:345-6.
18. Rahal JJ, Urban C, Segal-Maurer S. Nosocomial antibiotic resistance in multiple gram-negative species: experience at one hospital with squeezing the resistance balloon at multiple sites. Clin Infect Dis. 2002;34:499-503.
19. Ayan M, Durmaz R, Aktas E, Durmaz B. Bacteriological, clinical, and epidemiological characteristics of hospital acquired Acinetobacter baumannn infection in a teaching hospital. J Hosp Infect. 2003;54:39-45.
20. Aygun G, Demirkirian O, Utku T, Mete B, Urkmez S, Yilmaz M, et al. Environmental contamination during a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit. J Hosp Infect. 2002;52:259-62.
21. Landman D, Quale JM, Mayorga D, Adedeji A, Vangala K, Ravishankar J, et al. Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY, the preantibiotic era has returned. Arch Intern Med. 2002;162:1515-20.
22. Villegas MV, Hartstein AI. Acinetobacter outbreaks, 1977-2000. Infect Control Hosp Epidemiol. 2003;24:284-95.
23. Catalano M, Quelle LS, Jeric PE, DiMartino A, Maimone SM. Survival of Acinetobacter baumannii on bed rails during an outbreak and sporadic cases. J Hosp Infect. 1999;42:27-35.
24. Wendt C, Dietze B, Dietz E, Ruden H. Survival of Acinetobacter baumannii on dry surfaces. J Clin Microbiol. 1997;35:1394-7.
25. McDonald LC. Understanding and controlling the threat of multidrug-resistant Acinetobacter spp. Semin Infect Control. 2001;1:191-201.